High Purity 99.0%Min. Nootropic Compound 7p Powder CAS No.: 1890208-58-8

• Environmental Protection: Yes
• Color: White
• Function: Keeping Health and Promoting Growth
• Appearance: Powder
• Transport Package: 1kg/Foil Bag
• Specification: 99.0%min.
• Model NO.: Compound 7p
• Trademark: RunYan
• Origin: Zhongguo Hangzhou
• Production Capacity: 10000kg

Product Description

Product Description

High Purity 99.0%min. Nootropic Compound 7P Powder CAS NO.: 1890208-58-8
Systematic Name:YDL223C
Molecular Structure:C16H17F3N4O2S
Molecular Weight: 386.39
Chemical Properties:Light Yellow powder
Purity:99.0%min.
Package:1kg/foil bag
Uses:Nootropic
Description:
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor
antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.

Product Description

High Purity 99.0%min. Nootropic Compound 7P Powder CAS NO.: 1890208-58-8
Systematic Name:YDL223C
Molecular Structure:C16H17F3N4O2S
Molecular Weight: 386.39
Chemical Properties:Light Yellow powder
Purity:99.0%min.
Package:1kg/foil bag
Uses:Nootropic
Description:
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor
antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.